She was treated for fulminant type 1 diabetes. She maintained near-normal mealtime blood glucose levels (100-150 mg/dL) with insulin therapy at six units of insulin degludec before dinner, six units of insulin lispro before breakfast and lunch, and four units of insulin lispro before dinner. The gene discussed is INS; the disease is type 1 diabetes mellitus.